703 related articles for article (PubMed ID: 29566706)
1. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α
Li J; Chen Q; He X; Alam A; Ning J; Yi B; Lu K; Gu J
J Transl Med; 2018 Mar; 16(1):78. PubMed ID: 29566706
[TBL] [Abstract][Full Text] [Related]
2. α2-adrenoreceptor modulated FAK pathway induced by dexmedetomidine attenuates pulmonary microvascular hyper-permeability following kidney injury.
Chen Q; Yi B; Ma J; Ning J; Wu L; Ma D; Lu K; Gu J
Oncotarget; 2016 Aug; 7(35):55990-56001. PubMed ID: 27463003
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine alleviates cisplatin‑induced acute kidney injury by attenuating endoplasmic reticulum stress‑induced apoptosis via the α2AR/PI3K/AKT pathway.
Chai Y; Zhu K; Li C; Wang X; Shen J; Yong F; Jia H
Mol Med Rep; 2020 Mar; 21(3):1597-1605. PubMed ID: 32016445
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Ameliorates Post-CPB Lung Injury in Rats by Activating the PI3K/Akt Pathway.
Li J; Dou X; Li D; He M; Han M; Zhang H
J Invest Surg; 2020 Jul; 33(6):576-583. PubMed ID: 30913929
[No Abstract] [Full Text] [Related]
5. Dexmedetomidine attenuates renal ischemia-reperfusion injury through activating PI3K/Akt-eNOS signaling via α
Shan X; Zhang J; Wei X; Tao W; Peng K; Liu H; Wang Y; Liu H; Meng X; Ji F
FASEB J; 2022 Nov; 36(11):e22608. PubMed ID: 36250975
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
Liang S; Wang Y; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
[TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits.
Sun Z; Zhao T; Lv S; Gao Y; Masters J; Weng H
J Transl Med; 2018 Jul; 16(1):209. PubMed ID: 30031397
[TBL] [Abstract][Full Text] [Related]
8. Propofol can suppress renal ischemia-reperfusion injury through the activation of PI3K/AKT/mTOR signal pathway.
Wei Q; Zhao J; Zhou X; Yu L; Liu Z; Chang Y
Gene; 2019 Aug; 708():14-20. PubMed ID: 31082504
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Chang JH; Jin MM; Liu JT
Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion.
Li Q; Chen C; Chen X; Han M; Li J
Life Sci; 2018 Aug; 207():1-8. PubMed ID: 29729264
[TBL] [Abstract][Full Text] [Related]
11. Effect of Fc-Elabela-21 on renal ischemia/reperfusion injury in mice: Mediation of anti-apoptotic effect via Akt phosphorylation.
Xu F; Wu M; Lu X; Zhang H; Shi L; Xi Y; Zhou H; Wang J; Miao L; Gong DW; Cui W
Peptides; 2022 Jan; 147():170682. PubMed ID: 34742787
[TBL] [Abstract][Full Text] [Related]
12. PI3K/Akt pathway contributes to neuroprotective effect of Tongxinluo against focal cerebral ischemia and reperfusion injury in rats.
Yu ZH; Cai M; Xiang J; Zhang ZN; Zhang JS; Song XL; Zhang W; Bao J; Li WW; Cai DF
J Ethnopharmacol; 2016 Apr; 181():8-19. PubMed ID: 26805466
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion.
Bell MT; Puskas F; Bennett DT; Herson PS; Quillinan N; Fullerton DA; Reece TB
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):500-6. PubMed ID: 24035379
[TBL] [Abstract][Full Text] [Related]
14. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the JAK/STAT signaling activation.
Si Y; Bao H; Han L; Shi H; Zhang Y; Xu L; Liu C; Wang J; Yang X; Vohra A; Ma D
J Transl Med; 2013 Jun; 11():141. PubMed ID: 23759023
[TBL] [Abstract][Full Text] [Related]
15. 25-Hydroxyl-protopanaxatriol protects against H
Wang Z; Su G; Zhang Z; Dong H; Wang Y; Zhao H; Zhao Y; Sun Q
Biomed Pharmacother; 2018 Mar; 99():33-42. PubMed ID: 29324310
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
Dong W; Yang H; Cheng M; Zhang X; Yin J; Zeng Z; Huang G
Acta Biochim Pol; 2020 Dec; 67(4):521-529. PubMed ID: 33332077
[TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms.
Ma J; Chen Q; Li J; Zhao H; Mi E; Chen Y; Yi B; Ning J; Ma D; Lu K; Gu J
Anesth Analg; 2020 Apr; 130(4):1054-1062. PubMed ID: 30346356
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine attenuates remote lung injury induced by renal ischemia-reperfusion in mice.
Gu J; Chen J; Xia P; Tao G; Zhao H; Ma D
Acta Anaesthesiol Scand; 2011 Nov; 55(10):1272-8. PubMed ID: 22092133
[TBL] [Abstract][Full Text] [Related]
19. SC79, the AKT Activator Protects Cerebral Ischemia in a Rat Model of Ischemia/Reperfusion Injury.
Luan Q; Pan L; He D; Gong X; Zhou H
Med Sci Monit; 2018 Aug; 24():5391-5397. PubMed ID: 30074018
[TBL] [Abstract][Full Text] [Related]
20. Methane attenuates lung ischemia-reperfusion injury via regulating PI3K-AKT-NFκB signaling pathway.
Wang F; Wang F; Li F; Wang D; Li H; He X; Zhang J
J Recept Signal Transduct Res; 2020 Jun; 40(3):209-217. PubMed ID: 32079441
[No Abstract] [Full Text] [Related]
[Next] [New Search]
